Abbott Laboratories - 282410000

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2025 · Compare: Q3 2024
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
XXEC, Inc. History New 11,394 1,526 1.29% 1 +11,394 New Q3 2025 Nov 26, 2025
BANCO BILBAO VIZCAYA ARGENTARIA, S.A. History Closed out 0 0 0.18% -160,659 -100.0% Q3 2024 Nov 12, 2024